Aerin Medical Valuation, Funding & Investors

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.

EndoQuest Robotics is a US-based medical device company developing the ColubrisMX robotic system for minimally invasive fetal and neurosurgery. The platform enables access to uterine and intracranial spaces for treating spina bifida, tumors, and vascular malformations. Headquartered in Newark, California, EndoQuest collaborates with fetal medicine centers for clinical trials, aiming for procedures via 3mm incisions.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Convergent Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, that develops radiopharmaceuticals for cancer treatment. Its lead program, CONV01-alpha, is a radioantibody that binds to prostate-specific membrane antigen to deliver a radioactive payload selectively to prostate cancer cells while sparing healthy tissue. The company is building a broader pipeline of similar radioantibody therapies targeting prostate cancer and other solid tumors.

Restor3d is a Durham, North Carolina-headquartered medical device company specializing in 3D-printed orthopedic implants. The firm produces patient-specific titanium craniomaxillofacial plates, spinal spacers, and pelvic reconstruction devices using AI-optimized designs for osseointegration. FDA-cleared products serve surgeons at hospitals like Mayo Clinic, integrating digital planning software for precise anatomical fits in trauma and oncology cases.

Unlearn.AI is a clinical trial platform generating digital twins of patients using machine learning models trained on historical data. Its TwinRCT design accelerates biopharma studies by reducing required participants while maintaining statistical power for endpoints. Headquartered in San Francisco, the company partners with Pfizer and Roche on trials for Alzheimer's and oncology indications.

Tess Holdings Co Ltd is engaged in the development and electricity sales of renewable power plants and power retailing business. Further, it is also involved in the operation and maintenance of cogeneration and other environmental energy-saving systems.

Alleviant Medical develops the Alleviant Heart Stabilizer, a transcatheter mitral valve repair device for congestive heart failure patients. Inserted via femoral artery access, the implant reshapes the mitral annulus to reduce regurgitation and improve cardiac output. Targeting the 6 million US heart failure cases, the system aims to cut hospital readmissions by 50 percent in clinical trials. Based in Tampa, Florida, the company raised Series A funding in 2021 and plans FDA pivotal studies.

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Cloudnine Hospitals is an India-based chain of specialty hospitals focused on maternity, gynecology, neonatology, and pediatrics care. Operating 20 facilities in Bengaluru, Chennai, Gurgaon, Mumbai, Pune, and Chandigarh since 2007, it delivers over 50,000 births annually with level 3 NICUs and fertility centers. The network adheres to NABH accreditation standards, providing services like high-risk pregnancy management and pediatric surgeries. Cloudnine expands to additional cities including Delhi and Hyderabad, serving urban middle-class families.